Pharmaceutical R&D returns for the world's top 20 pharma companies have improved for a third consecutive year to 7%, thanks almost entirely to a handful of high-forecast assets such as glucagon-like peptide receptor agonists, or GLP-1s
Corresponding author Hui Shao, of the Emory University Rollins School of Public Health, in a statement cautioned that the use GLP-1 and SGLT2 therapies in T1D has increased sharply over the past decade, despite their safety concerns in this indicationincluding ketoacidosisa serious and potentially life-threatening complication that develops when the body fails to produce enough insulin
L-acetylcarnitine in the treatment of patients with peripheral neuropathies: a short term, double-blind clinical study of 426 patients
A legitimate, reputable provider or pharmacy will have transparent records, a verifiable professional history, and be open about their credentials, licensing, and oversight